Complete metabolic response as early predictor of long-term efficacy after adoptive T cell therapy using tumor-infiltrating lymphocytes
Introduction: Adoptive cell therapy using tumor-infiltrating lymphocytes (TILs) has proved to be an effective treatment for metastatic melanoma, even in patients failing anti-PD-1 blockade. Nevertheless, progression is observed in a substantial subgroup of patients following an initial objective res...
Saved in:
Main Authors: | Rikke Andersen, Troels Holz Borch, Eva Ellebaek, Inge Marie Svane, Helle Westergren Hendel, Kasper Madsen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-02-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/13/2/e010575.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer
by: Elizabeth T. Evans, et al.
Published: (2024-09-01) -
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy
by: Sarah Nikiforow, et al.
Published: (2024-02-01) -
18F-FDG PET/CT assessment of metabolic tumor burden predicts survival in patients with metastatic posterior uveal melanoma
by: Tine Gadegaard Hindso, et al.
Published: (2025-02-01) -
Prognostic value of tumor‐infiltrating lymphocytes and PD‐L1 expression in esophageal squamous cell carcinoma
by: Jie Hu, et al.
Published: (2024-09-01) -
Neutrophil to Lymphocyte Ratio as a Predictor of Adverse Outcome in Patients with Decompensated Liver Cirrhosis
by: Valeriy D. Lunkov, et al.
Published: (2019-03-01)